ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
United Health Products Inc (PK)

United Health Products Inc (PK) (UEEC)

0.0712
0.0047
(7.07%)
Closed 22 December 8:00AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.0712
Bid
0.0711
Offer
0.0838
Volume
458,058
0.06 Day's Range 0.0767
0.046 52 Week Range 0.269975
Market Cap
Previous Close
0.0665
Open
0.065
Last Trade
900
@
0.0712
Last Trade Time
Financial Volume
US$ 29,115
VWAP
0.063562
Average Volume (3m)
235,138
Shares Outstanding
250,083,222
Dividend Yield
-
PE Ratio
-6.67
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-2.62M

About United Health Products Inc (PK)

United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the dental, healthcare, veterinary and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, designed to absorb exudate/drainage from su... United Health Products Inc. (UEEC) develops, manufactures, and markets patented hemostatic gauze, for the dental, healthcare, veterinary and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural, designed to absorb exudate/drainage from superficial wounds and helps control bleeding. Show more

Sector
Ortho,prosth,surg Appl,suply
Industry
Ortho,prosth,surg Appl,suply
Website
Headquarters
Henderson, Nevada, USA
Founded
-
United Health Products Inc (PK) is listed in the Ortho,prosth,surg Appl,suply sector of the OTCMarkets with ticker UEEC. The last closing price for United Health Products (PK) was US$0.07. Over the last year, United Health Products (PK) shares have traded in a share price range of US$ 0.046 to US$ 0.269975.

United Health Products (PK) currently has 250,083,222 shares in issue. The market capitalisation of United Health Products (PK) is US$16.63 million. United Health Products (PK) has a price to earnings ratio (PE ratio) of -6.67.

UEEC Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.014224.91228070180.0570.07840.0464438060.06457699CS
4-0.0108-13.17073170730.0820.090.0463589250.06754717CS
12-0.0688-49.14285714290.140.1580.0462351380.0843211CS
26-0.0888-55.50.160.190.0461652040.11000065CS
52-0.1588-69.04347826090.230.2699750.0461582020.150939CS
156-0.5787-89.04446837980.64990.942550.0461456930.26793457CS
260-1.0988-93.91452991451.171.910.0461260480.50255264CS

UEEC - Frequently Asked Questions (FAQ)

What is the current United Health Products (PK) share price?
The current share price of United Health Products (PK) is US$ 0.0712
How many United Health Products (PK) shares are in issue?
United Health Products (PK) has 250,083,222 shares in issue
What is the market cap of United Health Products (PK)?
The market capitalisation of United Health Products (PK) is USD 16.63M
What is the 1 year trading range for United Health Products (PK) share price?
United Health Products (PK) has traded in the range of US$ 0.046 to US$ 0.269975 during the past year
What is the PE ratio of United Health Products (PK)?
The price to earnings ratio of United Health Products (PK) is -6.67
What is the reporting currency for United Health Products (PK)?
United Health Products (PK) reports financial results in USD
What is the latest annual profit for United Health Products (PK)?
The latest annual profit of United Health Products (PK) is USD -2.62M
What is the registered address of United Health Products (PK)?
The registered address for United Health Products (PK) is 569 VIA VENTANA DR, MESQUITE, HENDERSON, NEVADA, 89027
What is the United Health Products (PK) website address?
The website address for United Health Products (PK) is uhpcorp.com
Which industry sector does United Health Products (PK) operate in?
United Health Products (PK) operates in the ORTHO,PROSTH,SURG APPL,SUPLY sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.10
(99,900.00%)
100
GNTLFGenetic Technologies Ltd (PK)
US$ 1.00
(90,809.09%)
100
VIVEViveve Medical Inc (CE)
US$ 0.0003
(29,900.00%)
7.33k
BTIMBoatim Inc (CE)
US$ 0.0002
(19,900.00%)
799
CLVRClever Leaves Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
592
RAASYCloopen Group Holding Limited (CE)
US$ 0.000001
(-100.00%)
214
EWGFFEat Well Investment Group Inc (CE)
US$ 0.000001
(-100.00%)
47.01k
SOLBFSoLVBL Solutions Inc (CE)
US$ 0.000001
(-99.99%)
10k
HAVLFHavn Life Sciences Inc (CE)
US$ 0.000001
(-99.98%)
4.02k
ENDRFEndor AG (GM)
US$ 0.0001
(-99.98%)
560
HMBLHUMBL Inc (PK)
US$ 0.00095
(5.56%)
344.89M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
312.21M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(0.00%)
215.71M
RDARRaadr Inc (PK)
US$ 0.0014
(16.67%)
174.96M
CHNVFChina Youzan Ltd (PK)
US$ 0.0177
(10.63%)
100M

UEEC Discussion

View Posts
Waverunners Waverunners 1 day ago
Thanks Hoonigan. I’m not looking to debate your formula. However, please keep in mind that UHP is applying for a PMA for Gauze only.
Gauze makes up 25% of the Hemostatic market.
The rest is gels, powders etc.
The entire Hemostatic Gauze market is approximately $1 billion per year at this time.

BTW, Kevin O’Leary owns a ton of JnJ stock and it’s one of his top 10 picks. Maybe he should buy up some UEEC while he’s at it.
👍️0
Hoonigan Hoonigan 1 day ago
Made a mistake should be --- If the UEEC products get 10% of the market over the next five years that is $3 billion and they have 25% earning the company is worth $750 Million. Based on the standard 5 times earnings company cost valuation that the great Kevin O'leary uses, the stock is worth $3 a share. 5% of the market it is worth $1.5 (based 250 million shares). The missing facts are percentage of earnings and market share. If you have those to facts you have a solid valuation estimate.
👎️ 1 😂 1
Hoonigan Hoonigan 2 days ago
Wow 7 million shares sold in the last month 57% were long holds diluting the market with shares driving down the stock price to these crazy levels. I keep buying all I can and feel liking I am stealing shares but someone needed some cash or end of year right off really bad. We all know who sold 10 million shares and was a shame they had to sell them. I am positive UEEC is rounding up some serious investors for the new year.

Surgicel Absorbable Hemostat Market Size was valued at USD 4 Billion in 2023 and is expected to reach USD 9.7 Billion by 2031
Break out that calculator and visor to double check me, I did this really quickly in my head without coffee and with a flue bug! feel free to start slinging mud, I have my roll off goggles and helmet on.

Here is a link to a recent market analysis (link!!) Surgicel Absorbable Hemostat Market Size and Projections

If the UEEC products get 10% of the market over the next five years that is $3 billion and they have 25% earning the company is worth $1.5 billion. Based on the standard 5 times earnings company cost valuation that the great Kevin O'leary uses, the stock is worth $3 a share. 5% of the market it is worth $1.5 (based 250 million shares). The missing facts are percentage of earnings and market share. If you have those to facts you have a solid valuation estimate.

Let the mud fly!!!



👍️0
rodman rodman 2 days ago
Hopefully RFK and DOGE can rid the FDA of its in-efficiency and corruption that has been pervasive in the pharmaceutical industry for years! In the meantime here we are!
https://www.greenlight.guru/blog/fda-medical-device-approval-process
$5-$10+
👍️ 1
shoondale shoondale 2 days ago
If there is one iota of truth in what you state; please state why this piece of crap can't even sell over the counter in any country, anywhere on Earth. The FDA can only limit sales in the United States. It has been over a decade. Where are the over the counter sales?
👍️0
shoondale shoondale 2 days ago
"FIRST CLAIM FOR RELIEF
Violations of Exchange Act Section IO(b) and Rule 10b-5 Thereunder
(UHP and Beplate)
SECOND CLAIM FOR RELIEF
Violations of Exchange Act Section I0(b) and Rules IOb-S(a) and (c) Thereunder
(Schiliro)
THIRD CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section lO(b) and Rule 10b-5(b)
(Schiliro)
FOURTH CLAIM FOR RELIEF
Violations of Securities Act Section 17(a)
(All Defendants)
FIFTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a), 13(b)(2)(A) and 13(b)(2)(B)
of the Exchange Act and Rules 12b-20, 13a-1 and 13a-13 Thereunder
(UHP)
SIXTH CLAIM FOR RELIEF
Aiding and Abetting Violations of Exchange Act Section 13(a),
13(b)(2)(A), 13(b)2)B), and Rules 12b-20, 13a-1 and 13a-13
(Beplate and Schiliro)
SEVENTH CLAIM FOR RELIEF
Violation of Section 13(b)(5) of the Exchange Act and Exchange Act Rule 13b2-1
(Beplate and Schiliro)
EIGHTH CLAIM FOR RELIEF
Violations of Exchange Act Section 13(a) and Rule 13a-14 Thereunder
(Beplate)
NINTH CLAIM FOR RELIEF
Violations of Rule 13b2-2 of the Exchange Act
(Beplate and Schiliro)
TENTH CLAIM FOR RELIEF
Violations of Sarbanes-Oxley Act Section 304(a)
(Beplate)
ELEVENTH CLAIM FOR RELIEF
Violations of Exchange Act Section 16(a) and Rule 16a-3 Thereunder
(Beplate)"
https://www.sec.gov/files/litigation/complaints/2022/comp25413.pdf
👍️0
Waverunners Waverunners 2 days ago
Please stop lying. It helps no one.

“However, they put their name on Hemostyp when they declared it superior to the industry leader.”

And using this lie to support a false statement:

“They wouldn't do that if they weren't eventually going to approve it.”

I know this is just a message board and anything goes, but blatant lies have to be called out.

My hope is that UHP is on the right path going forward. But all these conspiracy theories, combined with lies are so unfortunate.

Hopefully, he is done posting in 2024.
If that’s the case, I look forward to reading the board in 2025 , when there are some REAL events to comment on.
👍️0
trusttheman trusttheman 2 days ago
The one thing I can't stress enough is this from what I've heard from people who have used the band-aids. If you use one, you will never go back to the J&J crap bandages again. Essentially, they are worthless compared to the Hemostyp band-aid. Then of course you get into all the surgeries that will be using Hemostyp which will become the standard of care the second they are approved which we all hope will happen. All these delays are happening for a reason. Some will blame the company for the delays. I'm sure they could have done some things differently. However, make no mistake. The corrupt FDA is nothing but a puppet for J&J. That is one huge reason the new administration under Trump is going to clean house on them. J&J's bread and butter has always been band-aids. When people find out they have to use one Hemostyp band-aid, maybe a second if the cut gets wet instead of 10 to 15 J&J band-aids and the wound heals 3 to 4 times faster with a hemostyp band-aid, it causes extreme fear for even the biggest pharm company out there. They can say whatever they want. J&J is afraid. No matter now small the possibility is that they might not be able to obtain UEEC's product. They're afraid. The last move the FDA pulled proves that. As I said before. Absolute corruption asking for more abdominal surgeries when you had 4 years to do so. It's a slimy, corrupt tactic that they can get away with because of the simple fact we are a small OTC company. However, they put their name on Hemostyp when they declared it superior to the industry leader. They wouldn't do that if they weren't eventually going to approve it. If these delays weren't so painful I would be laughing my ass off that a little OTC company with a game changing product is scaring the biggest bully pharm company on the planet. J&J always talks tough. Saying they won't chase something. Historical, they always overpay. Just imagine what they will pay for a product that not only will eliminate Surgicrap but could potentially wipe out their band-aid market.
👍️0
GetRch$lwly GetRch$lwly 2 days ago
Agree, wave and good point!. I don't think we will see any comment from the FDA other than an approval or denial when they finally feel they have enough information to make that decision.
👍️0
Waverunners Waverunners 2 days ago
Thanks GR$. Yes, UHPs clinical trials absolutely showed superiority. That is definitely a fact.
This PR wisely notes that the UHP team made this clear to the FDA in their discussion.
That was smart. In the quote you have provided “ the company (UHP)noted the results of its clinical trial.” That is great.

In no way does this indicate that the FDA has given Hemostyp (CelluStat) a superior rating.
👍️0
GetRch$lwly GetRch$lwly 2 days ago
Per UEEC's press release. They were the one to first use "superiority"

During the discussion, the company noted the results of its clinical trial involving 232 patients (of whom 118 were treated with its hemostatic gauze) that showed both non-inferiority and superiority for time to hemostasis using CelluSTAT (fka HemoStyp) relative to the standard of care and showed no evidence of heterogeneity of results across procedure categories, surgeons, or clinical sites, indicating both poolability and generalizability of study results.
👍️0
JimmyRich JimmyRich 2 days ago
I think we have more opinions than facts.. fact is we don’t have the information from the company that we need entirely and we are going off of hypotheses and I do think some of us have aspirations that are a bit too high but then again on this market nobody knows anything., I’ve seen totally useless pieces of shit run for no reason at all.. let’s hope we go the right way and get the proper fda approval because that is how I would like to see it play out.. no scams no pumps no stories.. just facts and an approval that makes us class 3 because that is what we really need
👍️0
Waverunners Waverunners 3 days ago
I almost made it to the end of 2024 without engaging with any more of this person’s posts, but this is so inaccurate that I just can’t help myself.

1. When did FDA give Hemostyp a superior rating. Trust says this twice.
“ The FDA as I said gave this a superior rating.”

2. DBnews was not “completely wrong “. Hemostyp (aka CelluStat) is a class 1 device that could be sold in retail.

3. It is not a class 3 device until it gets approved. It is a class 1 device. There was potential in this market but UHP decided to go all in on the PMA.

4. It didn’t go to $2.45 due to a “fast track announcement.” It was an unprecedented surge based on pumpers and MM creating a huge Shorting opportunity (remember White Diamond)

5. $20-30 per share. Sounds good, but just a made up number. DB’s numbers are far more realistic.

6. His Bandaid rant is hilarious. But he sure talks like an expert, though he has never bought or used the “band-aid aspect” of this product.” Somehow he knows one would require up to 15 more band aids. Why didn’t he spend $20 and buy the superior product? They were available to the general public yet he never bought (or used) a product he’s invested in, yet he boldly states “ The band-aid aspect of this product is going to put J&J in serious trouble if they don't get the product”

7. “ The projected current value of the company when it was appraised was 4 to 900,000 million.”
4 to 900,000 million. What the heck.
$900,000,000,000.00
That’s just wild.

8. The FDA conspiracy is odd. I’ll leave it at that.

Hoping for the best in 2025. To the posters asking intelligent questions and/or attempting to add a rational voice to this board, keep it up Please. Trust me, there are readers here that really do want to have those discussions. It’s just hard to get berated but the angry man.
👍️0
JimmyRich JimmyRich 3 days ago
Thank you for the reply I appreciate the info.. definitely good news.. let’s hope we’re on the way
👍️ 1
JimmyRich JimmyRich 3 days ago
Nice post.. very informative
👍️0
CHARLIESAN CHARLIESAN 4 days ago
The opinion was from a medical professional who is the smartest person I know. I think there has been commentary from board members who have stated that the approvals for Dental and Vets. were in place. A Annual Report a couple years back actually showed a $35,000 product sale for the only income stream I am aware of. I am not sure but the 35K sale of product may have been to a Dental operation. It was my understanding that these two approvals were obviously different from the in human surgical uses. IMO if they have these two approvals in place; the bottom worst case is far above the .05 cent range we now see. But I agree; the real hope is for the elements of our government not functioning in the public interest to be gone. Hope is in sight. Could we add a little "Joy"? LOL.
🤣 1
trusttheman trusttheman 4 days ago
Completely incorrect DBNews. This is a class 3 device. Almost impossible to get approved. They were already given a superior rating by the FDA to the only competitor for class 3 on the market. Which by the way is a pile of crap and was never FDA approved. Grandfathered in. I would be shocked if it didn't go to 3 to 5 dollars on approval. It went to $2.45 when they announced they were on the fast track program for the FDA. Which by the way obviously was a load of crap from the corrupt FDA who will soon have over half its criminal employees fired. I said from the beginning. 20 to 30 dollars if they get approval and sell the company. 4 to 6 billion for this product is fly sh!t for a major pharma company that gets this product. They will make that back in the first couple years. Oh and by the way. The band-aid aspect of this product is going to put J&J in serious trouble if they don't get the product. I know people that have used them. You use one of this companies band-aids. Stops bleeding. Heals the cut much faster. You don't use 7 to 15 more like you do with the regular band-aid crap. Believe me. J&J knows this. You are kidding yourself if you don't think they have stalled approval on this with the FDA. Their band-aid market will suffer massive losses to Hemosytp band-aids. Don't be fooled by the current share price. It's what happens when the FDA is corrupt, uses stalling techniques and the stock is on the pinks being heavily shorted. The FDA as I said gave this a superior rating. They can't stall forever. The projected current value of the company when it was appraised was 4 to 900,000 million. Sales price usually goes 6 to 8 times that. 4 dollar a share for each billion. 2 dollars a share would be if they couldn't get this to the finish line approval wise. Like I said. Take comfort in that the FDA firings are coming.
👍️ 3 🤣 1
JimmyRich JimmyRich 5 days ago
What is your opinion of the source that shared this opinion?? Obviously I would love for it to be the case because it’s progress and any progress is welcomed.. thanks in advance
🤣 1
CHARLIESAN CHARLIESAN 5 days ago
I had an opinion stated to me that the FDA approvals already in place for Vet. and Dental usages were in the worst case of
some reasonable value. That seems logical as a worst case. Any opinions out there on this assumption??
🤣 1
DBnews DBnews 6 days ago
New to board. Been watching board for many years listening to all your opinions on this stock. I bought in at the beginning at .09 per share (about 40000) shares. Sold about 15000 over the years at .65 to .75. Got all my money back as the original purchase was a whim. I have seen all the speculations about a pot of gold at the end of the rainbow. I saw the stock hit over $2.00 per share, was thrilled, only to see it drop. Now its below what I paid for it so many years ago. Any idiot who thinks this is going to $5 or $10 per share on a buyout is not a real investor. If the FDA ever approves this, and I mean ever, we would be lucky to get $2.00. That would be OK for me. Stop saying it is worth so much.
👍️0
Zorax Zorax 1 week ago
Looks like some shareholders are throwing in the towel.Got a link for that?
It's not for the faint of heart having to wait for the corrupt FDA...The FDA isn't corrupt,,, yet. It's their job and they do it well. The FDA waits on the uhp corp to deliver the proper paperwork. It's on the scam uhp to deliver the goods, they're the ones to blame, not the FDA. It's never been the FDA. Constant repeating it's someone else's fault doesn't make it true.

Just shows the company is a scam.
👍️ 3 👎️ 1 💥 3
Zorax Zorax 1 week ago
Nasdaq has never been considered ,,otcqb is what they have filed forThen that is NOT an uplisting. It is a forever pump lie for ceo's to claim they are uplisting when it's only paying a higher fee to otcm advertising service to get new 'initials' added to their name. Junk talk. Like this junk stock.
👍️ 1 💯 1
JimmyRich JimmyRich 1 week ago
We have no choice but to wait at this point we’re this deep might as well go all the way… but about yesterdays posts.. we’re hardly heavily shorted no question
👍️0
trusttheman trusttheman 1 week ago
Looks like some shareholders are throwing in the towel. It's not for the faint of heart having to wait for the corrupt FDA to give up with their nonsense. I can wait a little longer.
👍️0
rodman rodman 1 week ago
Thanks for your work Trust! It its any consolation the short bashers only bash good stocks!
$5-$10+
👍️0
trusttheman trusttheman 1 week ago
You can see here the way this stock is shorted and has been for a very long time.

https://www.otcshortreport.com/company/UEEC
👍 2
Chrism0000 Chrism0000 1 week ago
Heads must roll!!!!
👍️0
Hoonigan Hoonigan 2 weeks ago
Wow someone needs some cash before Christmas that just got a ton of shares to sell at these low bargain prices and volume. It is a shame that they have to sell and dilute the market to get some cash. But it is a Great Christmas present buying opportunity! I will keep buying all day long at $.061 what a steal.

Looks like robot Santa loaded his sleigh up with stock too and is out doing some shenanigans!
👍️0
JimmyRich JimmyRich 2 weeks ago
Very interesting I didn’t know that again thanks for the info and let’s hope this is moving us toward the uplisting..
👍️0
rodman rodman 2 weeks ago
Actually closer to 35 then he gave 1+ million shares back to the company in partial payment of his SEC ruling. He then put 18 million into a grantor trust with a trustee empowered to control the trust assets so he basically divested himself of all but the 6.7 million.
Interesting!
👍️0
JimmyRich JimmyRich 2 weeks ago
Thank you
👍️0
GetRch$lwly GetRch$lwly 2 weeks ago
Based on my experience, I'm guessing this was done to clarify some questions related to the OTCQB uplift filing. This would also explain why something that normally takes 6 -8 weeks still hasn't been completed.
👍️0
JimmyRich JimmyRich 2 weeks ago
Thoughts?? Didn’t he own like 30 million + in shares?
👍️0
rodman rodman 2 weeks ago
Former CEO filed and SEC required statement to indicate his percentage of ownership decreased. Not sure what the overall implication is but he now only controls 6,700,000 shares of UEEC.

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318767261&type=HTML&symbol=UEEC&cdn=bb1a4e05e3671da42927a9f4a730762f&companyName=United+Health+Products+Inc&formType=SC+13D%2FA&formDescription=%5BAmend%5D+General+statement+of+acquisition+of+beneficial+ownership&dateFiled=2024-12-04
👍️0
JimmyRich JimmyRich 3 weeks ago
As usual very well said
👍️0
JimmyRich JimmyRich 3 weeks ago
As usual very well said
👍️0
dogooder dogooder 3 weeks ago
Nasdaq has never been considered ,,otcqb is what they have filed for, will it help,,maybe yes, maybe no,,but it won't hurt, they need to execute on the plan they have laid out, credibility is severely compromised, execution of the plan is the only way to regain trust in management.
👍️ 2
Zorax Zorax 3 weeks ago
I agree with you on the uplistinglmao. Uplisting to another tier of otcm advertising service isn't worth the electricity of typing it.
And if anyone is thinking nasdaq, this scam would need at least two years of trading at above 5 bucks. And at least 3 years of income. Not going to happen.

Ever...
👍️0
Hoonigan Hoonigan 3 weeks ago
Amen and someone got some race gas in the engine when the shares dropped to this crazy low price. Hopefully everybody picked up the cheap shares, I know my trucks are full. Their no longer diluting the stock shares anymore with White Lion which is great news and going with more conventional investors to get this over the finish line as fast as they can. Thank the big man in the box seat that someone saw the light. I spent some time following the money trail and was going to do a post on it -- If you look at White Lion's companies they invest into with the same deal as UEEC got, their charts are identical to UEEC and the companies are all at the white flag lap and need some cash, then the stock goes to a record low and they need more cash. There's a pattern - high risk and reward investing or something else?

Time for more race gas and burnouts! We all know the trials are a slam dunk then cha-ching, cha-ching!

👍️0
rodman rodman 3 weeks ago
Hell YES! UEEC has NOT been sitting on their hands! Time for a run up to .20 without White Lion and hopefully not a PPA!
$5-$10+
👍️0
dogooder dogooder 4 weeks ago
I agree with you on the uplisting, it has been way longer than it should take, so hopefully there have been no issues with the filing and should be approved very soon, also hoping we get some news on upcoming surgeries, would be great to be able to complete them quickly once all the filings are done, lots of positives looking forward, I hope
👍 1
trusttheman trusttheman 4 weeks ago
That's a good point Dogooder. The tax strategy is very real this time of year. I also hope they will be uplisted next week from the pink sheets. So, you might be looking for shorts to get in all they can before the holiday. I've actually used the product. It's obscene how good it is. It's also laughable how bad Surgicrap is. However, sadly I have learned that the FDA doesn't care at all about saving lives. They are corrupt. All the care about is money and keeping their jobs. Much like the SEC. Thus, why this new administration is going to clean house on both of them.
👍️ 1
JimmyRich JimmyRich 4 weeks ago
Let’s hope you are right and the new administration changes a lot of things for the better and those changes help pave the way for Ueec
👍️ 1
trusttheman trusttheman 4 weeks ago
I'm not saying the company hasn't made several mistakes along the way. They most certainly have. However, this 6 month delay is Corrupt FDA 101. Absurd to ask for more abdominal testing when they could have done so 1,2,3,4 years ago. Everybody working in pharm knows the corrupt FDA is a puppet for J&J. Now they have an administration with full power that is going to unleash on them. Long overdue. I suspect you will see resignations soon in the FDA much like you are starting to see in the SEC.
👍️ 1
dogooder dogooder 4 weeks ago
If you believe in this product, have ever used it for whatever reason, you will know why many of us are willing to stick this out, most of the pressure on the stock is tax loss selling, why not, imagine most investors have huge gains year to date, so using the losses in ueec makes sense, they don't care what they sell it for , the lower the better.
This however represents a great opportunity to buy stock, people who believe, and those willing to sell at the lowest price possible. I believe we hear something very soon related to the surgeries yet to be done.
👍️ 1
JimmyRich JimmyRich 4 weeks ago
Trust most likely you’re pretty spot on.. I also had said 6 months at least.. Truth we’re all holding pretty heavy and 6-7 months for the true payday isn’t asking much even though as you and most others are.. we’re getting tired but we can’t give up in the homestretch.. time will tell.. none of us know for sure what will happen.. let’s just try and stay optimistic
👍️ 1
JimmyRich JimmyRich 4 weeks ago
Excellent post.. Thank you and I certainly appreciate your opinion and honestly I share the same thoughts as far as life has moved on without it.. I actually am optimistic that this happens but I have to be realistic at the sane time.. Again thank you for your response
👍️0
trusttheman trusttheman 4 weeks ago
Ignore him. He's not a shareholder. He's a short. He's done nothing but bash the stock from day one. Making up lies before the holiday to upset longs. What is happening is common sense. One, the company got f'd over by the corrupt FDA with this additional abdominal testing request to make the ratio larger to the vascular testing when they could have done that many years ago after clinical trials. So, they said 6-7 months. Thus, you probably have some people that are willing to sell shares even for not much return, put it in stuff like crypto or something else they think is going up soon and then buy back later. Second, the company is on the pink sheets which is a shorts dream. That's because hundreds of brokerage houses won't let you trade a stock on the pinks. So a big guy who buys through his brokerage house isn't going to be able to come in, pick up a million shares, drive the stock price up and catch the shorts. Most investors aren't patient. As patient as the longs of this company are, if they were told 6 to 7 months because of this corrupt FDA move, they are more likely to sell than buy for the near future. What I do know is talking about matching up the product from the U.S. to the China plant is horsecrap. That was done a long time ago which is why they submitted a complete PMA. The SEC, FDA, all are going to get hammered when Trump gets in office with full legislative power.
👍️0
Waverunners Waverunners 4 weeks ago
Jimmy, I only know how to give realistic fact based summaries. If this is what you want, read below.

The last major spike in share price came in September/Oct 2020. And then again May/June 2021. I believe you were starting to get interested in this stock around that time. Not sure if you bought it though. For your sake hopefully not at the Sep/Oct 2020 prices.
There was plenty of PMA excitement and PRs at the time.

https://uhpcorp.com/united-health-products-submits-hemostyp-completed-pma-response-to-fda/

Unfortunately we are all aware of the repeated delays and PRs to follow for 4 years which brings us to today.

It really doesn’t matter whose fault it is or what government agency people want to blame. At this point I imagine there is overwhelming investor fatigue. Many like myself held on to 10 cent shares that we could have sold for over $2.00, in hopes that the real payday would be even richer. And who knows, it may be.

If you read my first ever post on here you will see I was predicting an eventual payout of $3.10 per share.
Even in my infamous Memorial Day 2023 post I still predicted $2-3.50 pps. (Still not positive enough for some)

My guess is a lot of the low entry price investors have just plain old had enough and are agreeing to sell at these prices to just get out and move on. Take a little loss or a little win. This will likely continue as other investors that are assuming a loss will get out for tax reasons and possibly buy back in 2025.
For me, I’m holding onto my shares. I spent the money a long time ago. So life has moved on without it.

For the record I am considering buying more. I thought UEEC was a value when I originally bought in at these prices, and as it turns out we are obviously (on paper anyway) closer to PMA then we were then.

I do feel that one day PMA will happen. Until then, I will just monitor this board and give my opinions when I see fit.
👍️ 1
JimmyRich JimmyRich 4 weeks ago
Wave the only thing that we should be concerned with here is that we traded some volume here today but I’ts all on the self side.. we can agree volume good price down bad.. any thoughts on what’s happening? Because whether you know it or not I know you have been on here forever and I do value your opinion.. thanks in advance
👍️0

Your Recent History

Delayed Upgrade Clock